Publication

Prescribing for Diabetes in England - 2005/06 to 2014/15

This is part of Prescribing for Diabetes

Official statistics
Publication Date:
12 Aug 2015
Geographic Coverage:
England
Geographical Granularity:
Primary Care Trusts, Clinical Commissioning Groups
Date Range:
01 Apr 2005 to 31 Mar 2015

Summary

This report shows prescribing trends for medicines prescribed in primary care in England for the treatment of diabetes for the period April 2005 to March 2015.

This is the latest in a series of annual reports published by the Health and Social Care Information Centre (HSCIC) on Prescribing for Diabetes in England, within primary care.

Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.

Note:  The last sentence of the second bullet point on page 4 in the Executive Summary has been corrected as at 14th August 2015 to show the total cost of prescribing for diabetes in 2005/06 as £513.9million.

The csv file has been corrected as at 1st September 2015 to replace organisation codes that were corrupted as part of the update on the 14th August.

We apologise for any inconvenience caused.

Key Facts

  • In 2014/15 there were 47.2 million items prescribed for diabetes (BNF section 6.1) at a net ingredient cost of £868.6 million.
  • In 2014/15 Prescribing for diabetes accounted for 4.5 per cent of total items prescribed and 10.0 per cent of the total cost of all prescribing. 
  • In 2014/15 there were 6.7 million items of insulin prescribed (BNF 6.1.1), at a net ingredient cost of £334.7 million.
  • In 2014/15 there were 33.4 million items prescribed for Antidiabetic drugs (BNF 6.1.2), representing 70.8 per cent of all items for diabetes, at a net ingredient cost of £350.2 million.
  • Since 2005/06, Antidiabetic drugs items prescribed have increased by 107.0 per cent and net ingredient cost by 138.6 per cent.

Resources

Related Links